All I want is Food on the TableA possible tech solution to help with the continued and growing Food Crisis and unpredictable weather
Upside: Not vulnerable to weather, increasing Food Prices could make AgTech more profitable over time
Downside: AgTech utilizes alot of Electricity Cost
IVN on the move againAs you can see from my markups on the Daily chart, Ivanhoe Mines (#IVN) is on the on the move again however has a couple of major milestones to break through... As you can see we have two trend-lines we are approaching, one being a shorter term ascending trend-line, the other being a longer term descending trend-line. Historically, IVN trades well when working with trend-lines so I am anxious to see this round how we respond to the upcoming/approaching trend-lines. Overall I am bullish on IVN. I am looking to make a higher-high to the ascending trend line. Lets wait to see how this pans out. Cheers everyone and remember, trade safe!
First Majestic: Refinishing…Like an artist with their painting, a craftsperson with their handiwork or a cook with their most exquisite dish, First Majestic seems not yet ready to let go of its work in the turquoise zone between $12.36 and $6.89 and apparently wants to add a finishing touch. Thus, it has arched back downwards and could aim for completing wave 2 in turquoise a bit deeper still in the turquoise zone. As soon as the current downwards movement is concluded, though, First Majestic should turn upwards and head for the resistance at $19.41. However, there is a remarkable 45% chance that First Majestic could break through the bottom of the turquoise zone and drop below the support at $5.30, which would then trigger further downwards movement.
still some juice leftstill some juice left still some juice left still some juice left still some juice left
Zinc8 Energy Solutions Inc. CSE: ZAIRSUPERCHARGING UPSTATE NEW YORK TO A BATTERY MANUFACTURING HUB: Senator Chuck Schumer supports Zinc8 expansion plans
Zinc8`s cutting-edge battery technology aligns perfectly with his work to expand battery storage capabilities in the Bipartisan Infrastructure Law.
www.rockstone-research.com
$NRX.V Outpaces Biotech Peers Following TSX.V Listing The biotech sector is presenting exciting opportunities for investors despite the broader downturn in global equity markets. Many of the best biotech companies and ETFs have both strong drug candidate pipelines in the works as well as winning drugs and therapeutic products already on the market. The COVID-19 pandemic has proven and created massive opportunities for the biotechnology sector as a whole, particularly so around innovative players that are developing therapeutic solutions with disruptive potential.
One new player to the field is Nurexone Biologic (NRX.V), a new listee on the TSXV exchange that is redefining exosome therapeutics for application to traumatic brain and spinal cord injuries. It is creating a platform for biologically-guided ExoTherapy that will be administered minimally invasively to patients who have had catastrophic spinal cord injuries.
Since July 15th, NRX +26% as it attracts new investors and institutional players begin to trade the equity. In comparison, the TSX/SPX composite index charted 6% gains, indicating that NRX far outperformed the market baseline over the course of the summer rally. Relative to sectoral ETFs, Nurexone is also trading strong. IBBQ is +6.9% and XBI +6% over the same timeframe NRX is +26%; it is important to note that over this period, the company did not release any price sensitive announcements that would otherwise account for its significant bullish price movement.
Further, exosome-based equities are one area of the wider biotech industry that has continuously traded robustly despite subpar performance for equity markets this year. Sectoral competitors are mixed bag, with KMPH +4.8% while APTO is down 4.4%. Kodiak Biosciences (KOD) jumped 20%, though it still lags behind NRX's 26% increase. This indicates that as exosome therapeutic developers struggle to maintain forward momentum amidst the backdrop of a challenging macroeconomic landscape, NRX is outperforming both sectoral ETFs and direct competitors. Though its a newby to capital markets, so far Nurexone is standing out as the bullish outlier with LT potential.
GXE long Entered GXE long here. Looking to back test the 236. We've stopped on major MA support. Usual 3 stage stop loss MGMT.
CCO longIts been a while. Lots of hand sitting this month. Finally a few stocks are moving the right direction.
Entry here in CCO Long. Bounced off the long term 0.382. looking for short term run to 0.5. 3/8 trap triggered entry. 1st target of %10 hit so took 1/3 off. Stop moved into slight profit for protection.
Accumulating Uranium stocks at this time so looking at how to hold last 3rd for a long period. Will update plan as it develops.
TMD - STOCK - LONG - ASCENDING TRIANGLETITAN MEDICAL INC. STOCK displays an ascending triangle pattern. Entry is at the breakout of the pattern make sure this coincides with a volume increase to verify breakout.
Exit is shown in the chart (Flag).
CRAFTPORT CANADASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
SILVER PREDATOR CANADA Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions